Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CDCA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GLO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EYA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADSL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAF9B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM64 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR4680 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LY75-CD302 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MARC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDC16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SSB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HMMR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTC3P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMARCE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TIMM17A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRSF8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAFAH1B1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on